Osteosarcoma (Q73923807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Osteosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

J S Whelan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1611-8; discussion 1618-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

publication type of scholarly work

7 November 2019

review article

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

1 reference

7 January 2021

Osteosarcoma after the fourth decade. A clinico-pathological review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Second primary neoplasms in patients with retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Bone sarcomas linked to radiotherapy and chemotherapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Mortality from second tumors among long-term survivors of retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Should cancer survivors fear radiation-induced sarcomas?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Bone and haematopoietic defects in mice lacking c-fos

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Studies of the RB1 gene and the p53 gene in human osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Alterations of the p15, p16,and p18 genes in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

SAS is amplified predominantly in surface osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Prognostic factors in osteosarcoma: a critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Tumor size and prognosis in aggressively treated osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

High-dose methotrexate: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

The role of methotrexate in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Methotrexate pharmacokinetics and prognosis in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Analysis of P-glycoprotein expression in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Pulmonary nodules: detection with thick-section spiral CT versus conventional CT

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Osteosarcoma: chemotherapy-induced changes at MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathologic response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarter

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Ifosfamide in pediatric malignant solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Etoposide (VP-16-213). Current status of an active anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

The metastatic patterns of osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Multiple pulmonary resections in the treatment of osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Aggressive thoracotomy for pulmonary metastatic osteogenic sarcoma in children and young adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Median sternotomy and multiple lung resections for metastatic sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Surgical treatment and chemotherapy for pulmonary metastases from osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Chemotherapy and thoractomy for metastatic osteogenic sarcoma.A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Osteogenic sarcoma with clinically detectable metastasis at initial presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Synchronous multifocal osteosarcoma: results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bones

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Treatment of pelvic osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Primary treatment of pelvic osteosarcoma. Report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900251-7

7 January 2021

10.1016/S0959-8049(97)00251-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389923%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference